The protein kinase C inhibitor, CGP 41 251, reverses decreased daunomycin uptake in a human drug-resistant ovarian carcinoma cell line.
Chorváth
B
B
Sedlák
J
J
Novotný
L
L
D000470:Alkaloids / Q000494:pharmacology*; D003630:Daunorubicin / Q000493:pharmacokinetics*; D004351:Drug Resistance; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D010051:Ovarian Neoplasms / Q000378:metabolism*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D019311:Staurosporine / Q000031:analogs & derivatives; D014407:Tumor Cells, Cultured
D000470:Alkaloids; D011493:Protein Kinase C; D019311:Staurosporine; C059539:midostaurin; D003630:Daunorubicin